SCHEMBL382220

SCHEMBL382220

CC([O])N1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL194338 0.97
SCHEMBL5244018 0.90
SCHEMBL5241067 0.83
SCHEMBL3955463 0.77 FDPS (0.37)
SCHEMBL6329689 0.75
SCHEMBL4365463 0.75 CHRNA7 (0.37)
SCHEMBL17025210 0.75 CHRM5 (0.36)
SCHEMBL18085480 0.73 CHRNA7 (0.40)
SCHEMBL19286390 0.73 SMN1; SMN2 (0.43)
SCHEMBL19965987 0.73 CHRNA7 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3952995-A1 BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS Riboscience LLC (US) 2022-02-16 EP claimed
WO-2020210649-A1 BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC (US) 2020-10-15 WO claimed
CN-111514123-A Application of ketorolac analogue in resisting virus infection 江苏伯克生物医药股份有限公司 2020-08-11 CN claimed
US-20190322676-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARM INC (US) 2019-10-24 US claimed
WO-2018118838-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2018-06-28 WO claimed
US-9908892-B2 Melampomagnolide B derivatives BIOVENTURES, LLC (US) 2018-03-06 US claimed
US-20160368929-A1 MELAMPOMAGNOLIDE B DERIVATIVES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2016-12-22 US claimed
US-9469650-B2 Melampomagnolide B derivatives BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2016-10-18 US claimed
US-9238640-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2016-01-19 US claimed
US-20150133444-A1 MELAMPOMAGNOLIDE B DERIVATIVES BIOVENTURES, LLC 2015-05-14 US claimed
US-20010039285-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists CAMERON KIMBERLY O (US) 2001-11-08 US claimed
EP-1113007-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists PFIZER INC. (US) 2001-07-04 EP claimed
EP-0764150-B1 PRODUCTION OF HYDROXYTHIOACETAMIDES AND USE THEREOF IN THE SYNTHESIS OF BENZOTHIOPHENES LILLY CO ELI (US) 1999-10-27 EP claimed
US-5589477-A LEARNING ENHANCEMENT, CNS NIPPON SHINYAKU COMPANY, LIMITED (JP) 1996-12-31 US claimed
US-5324736-A Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-06-28 US claimed
EP-0362695-B1 PYRROLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-04-03 EP claimed
EP-0410358-A1 Aromatic carboxylic acid amides, their preparation and their use as medicines F. HOFFMANN-LA ROCHE AG (CH) 1991-01-30 EP claimed
EP-0362695-A1 Pyrrolocarbazole derivatives, processes for their preparation and their use as medicaments GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-04-11 EP claimed
US-4912107-A Pyrrolocarbazole derivatives, compositions containing them, and methods for using them GOEDECKE AKTIENGESELLSCHAFT (DE) 1990-03-27 US claimed
US-4558046-A ANTIALLERGENS FARMITALIA CARLO ERBA, S.P.A. (IT) 1985-12-10 US claimed